복강 내압 측정 장비 시장 : 제품 유형, 기술, 휴대성, 환자 유형, 용도, 최종 사용자, 유통 채널별 - 세계 시장 예측(2026-2032년)

The Intra-abdominal Pressure Measurement Devices Market is projected to grow by USD 344.98 million at a CAGR of 9.35% by 2032.

Intra-abdominal pressure measurement devices are becoming essential tools in critical care, trauma, emergency surgery, burns, severe pancreatitis, liver failure, and high-risk postoperative care. The clinical rationale is well established: the World Society of the Abdominal Compartment Syndrome defines intra-abdominal hypertension as sustained or repeated intra-abdominal pressure of 12 mmHg or higher, while abdominal compartment syndrome is typically defined as pressure above 20 mmHg with new organ dysfunction.

For hospitals, these devices support earlier detection of physiologic deterioration affecting renal perfusion, respiratory mechanics, hemodynamics, and tissue oxygenation. Bladder-based measurement remains the widely accepted reference approach in routine adult intensive care practice, and demand is increasingly shaped by the need for standardized, closed, accurate, and workflow-friendly intra-abdominal pressure monitoring solutions.

Transformative Shifts in the IAP Monitoring Landscape

The intra-abdominal pressure monitoring landscape is shifting from ad hoc, manual measurement toward protocol-driven monitoring embedded in intensive care workflows. Hospitals are prioritizing closed systems, disposable components, calibrated transducers, electronic documentation, and staff training to reduce variability and infection risk while improving repeatability.

Another major shift is the move from isolated pressure readings to integrated decision support. Intra-abdominal pressure data is increasingly evaluated alongside fluid balance, vasopressor use, ventilator parameters, urine output, lactate, renal function, and sepsis indicators. This is transforming intra-abdominal pressure measurement devices from niche monitoring accessories into strategic tools for organ-protection protocols and high-acuity patient management.

Cumulative Impact of AI on Intra-Abdominal Pressure Monitoring

Artificial intelligence is not replacing clinical judgment in intra-abdominal pressure monitoring, but it is strengthening the value of pressure data when combined with electronic health records, bedside monitors, laboratory results, imaging findings, and nursing documentation. AI-enabled models can help identify patients at elevated risk of intra-abdominal hypertension by detecting patterns in fluid resuscitation, ventilator pressures, oliguria, shock, and inflammatory markers.

The cumulative impact is strongest in workflow optimization, early-warning dashboards, protocol adherence, and retrospective quality improvement. However, adoption depends on validated algorithms, interoperable devices, transparent model governance, cybersecurity safeguards, and clinician oversight to avoid alert fatigue or unsafe automation.

Key Regional Insights: Asia-Pacific, North America, Europe, Latin America, Middle East, and Africa

Asia-Pacific is gaining importance as China, India, Japan, South Korea, and Australia expand critical care capacity, upgrade tertiary hospitals, and standardize trauma and emergency surgery pathways. Rising surgical complexity, high population density in major urban centers, and investment in emergency and intensive care services are reinforcing the role of intra-abdominal pressure measurement devices across advanced and developing hospital systems. North America remains a mature adoption environment supported by advanced ICU infrastructure, broad electronic health record penetration, strong clinical education, and purchasing preference for devices that integrate with established monitoring systems.

Europe benefits from guideline-driven critical care practice, high awareness of sepsis and trauma care, and regulatory emphasis on medical device safety, performance, and post-market surveillance. Latin America shows selective adoption in Brazil and Mexico, where private hospital networks and tertiary centers lead use in trauma, emergency surgery, and high-acuity postoperative care. The Middle East is supported by hospital investment in GCC countries, medical tourism, trauma care modernization, and specialist ICU development, while Africa remains opportunity-rich but constrained by critical care capacity, procurement budgets, consumable availability, and training gaps.

Key Group Insights: ASEAN, GCC, European Union, BRICS, G7, and NATO

ASEAN markets are shaped by hospital modernization, rising surgical volumes, and expanding intensive care capabilities in Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines, with adoption led by tertiary hospitals and private networks. GCC adoption is concentrated in high-acuity public and private hospitals investing in advanced trauma, transplant, bariatric, emergency, and critical care services, where standardized monitoring and infection-control features are valued.

The European Union is influenced by Medical Device Regulation compliance, harmonized safety expectations, clinical evidence requirements, and strong adoption of evidence-based ICU protocols. BRICS countries combine large patient volumes with increasing local manufacturing interest, cost-sensitive procurement, and uneven access between metropolitan tertiary centers and resource-limited facilities. G7 markets lead in digital integration, clinical standardization, interoperability, and quality-improvement programs, while NATO-aligned health systems place additional emphasis on trauma readiness, military medicine, mass-casualty response, and disaster-response capability.

Key Country Insights Across Major Healthcare Markets

The United States leads adoption through advanced ICU infrastructure, trauma networks, academic medical centers, and strong integration of bedside monitoring with electronic records, while Canada emphasizes standardized critical care practice, patient safety, and value-based procurement. Mexico and Brazil show demand in large urban hospitals and private systems, particularly for trauma, emergency surgery, burns, sepsis management, and high-acuity postoperative care.

In Europe, the United Kingdom, Germany, France, Italy, and Spain benefit from mature hospital systems, trained critical care workforces, and guideline-led ICU practice, while Russia represents a large but unevenly resourced market with adoption concentrated in major urban and specialist centers. China and India offer significant clinical relevance as ICU capacity expands and surgical and trauma workloads increase; Japan and South Korea favor high-quality, precise, and digitally integrated devices aligned with advanced hospital workflows; and Australia supports adoption through sophisticated tertiary care, emergency medicine infrastructure, and established critical care protocols.

Actionable Recommendations for Industry Leaders

Industry leaders should position intra-abdominal pressure measurement devices around measurable clinical value: early detection, standardized protocols, reduced measurement variability, and support for organ-protection strategies. Product portfolios should prioritize closed bladder measurement systems, ease of setup, accurate transduction, infection-control features, compatibility with ICU monitors, and electronic health record connectivity.

Commercial teams should invest in clinician education aligned with WSACS definitions and hospital protocols. Manufacturers should strengthen evidence generation through real-world studies, usability testing, and health economic assessments focused on workflow efficiency, ICU decision-making, and preventable organ dysfunction. Regional strategies should balance premium connected systems in mature markets with cost-effective, training-supported solutions for emerging hospitals.

Research Methodology

This executive summary is developed using a structured market intelligence approach that combines peer-reviewed clinical literature, critical care guidelines, regulatory references, hospital procurement signals, publicly available product information, and expert interpretation of ICU workflow trends. Priority is given to verifiable sources, including consensus definitions for intra-abdominal hypertension and abdominal compartment syndrome.

The analysis triangulates clinical need, technology adoption, regional healthcare infrastructure, regulatory environment, and buyer behavior. It avoids unsupported market claims and emphasizes evidence-backed drivers such as critical care capacity, trauma burden, sepsis management, surgical complexity, digital health adoption, infection prevention, interoperability, and demand for standardized patient monitoring.

Conclusion

Intra-abdominal pressure measurement devices occupy a clinically important position in the early recognition and management of intra-abdominal hypertension and abdominal compartment syndrome. Their relevance is increasing as hospitals focus on preventable organ dysfunction, protocol adherence, ICU efficiency, infection control, and safer postoperative care.

Future adoption will be shaped by closed-system design, digital integration, clinician training, and AI-supported risk detection. Suppliers that combine clinical accuracy, workflow simplicity, regulatory compliance, interoperability, and regional affordability will be best positioned to serve critical care teams across mature and emerging healthcare systems.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Intra-abdominal Pressure Measurement Devices Market, by Product Type

• 7.1. Disposable Devices
  • 7.1.1. Disposable Pressure Transducers
  • 7.1.2. Disposable Catheters
• 7.2. Reusable Devices
  • 7.2.1. Reusable Pressure Transducers
  • 7.2.2. Reusable Catheters
  • 7.2.3. Monitoring Systems
• 7.3. Accessories
  • 7.3.1. Drainage Bags
  • 7.3.2. Extension Lines

8. Intra-abdominal Pressure Measurement Devices Market, by Technology

• 8.1. Conventional
  • 8.1.1. Fiber Optic Transducer
  • 8.1.2. Pressure Transducer
• 8.2. Telemetric
  • 8.2.1. Inductive
  • 8.2.2. Infrared
• 8.3. Wireless
  • 8.3.1. Bluetooth
  • 8.3.2. Rf

9. Intra-abdominal Pressure Measurement Devices Market, by Portability

• 9.1. Portable
• 9.2. Stationary

10. Intra-abdominal Pressure Measurement Devices Market, by Patient Type

• 10.1. Adult
• 10.2. Pediatric
• 10.3. Neonatal

11. Intra-abdominal Pressure Measurement Devices Market, by Application

• 11.1. Ambulatory Monitoring
• 11.2. Critical Care
• 11.3. General Surgery
• 11.4. Trauma Care
• 11.5. Organ Failure Management

12. Intra-abdominal Pressure Measurement Devices Market, by End User

• 12.1. Ambulatory surgical centers
• 12.2. Specialty clinics
• 12.3. Hospitals
• 12.4. Academic & Research Institutes

13. Intra-abdominal Pressure Measurement Devices Market, by Distribution Channel

• 13.1. Offline
• 13.2. Online

14. Intra-abdominal Pressure Measurement Devices Market, by Region

• 14.1. Asia-Pacific
• 14.2. North America
• 14.3. Latin America
• 14.4. Europe
• 14.5. Middle East
• 14.6. Africa

15. Intra-abdominal Pressure Measurement Devices Market, by Group

• 15.1. ASEAN
• 15.2. GCC
• 15.3. European Union
• 15.4. BRICS
• 15.5. G7
• 15.6. NATO

16. Intra-abdominal Pressure Measurement Devices Market, by Country

• 16.1. United States
• 16.2. Canada
• 16.3. Mexico
• 16.4. Brazil
• 16.5. United Kingdom
• 16.6. Germany
• 16.7. France
• 16.8. Russia
• 16.9. Italy
• 16.10. Spain
• 16.11. China
• 16.12. India
• 16.13. Japan
• 16.14. Australia
• 16.15. South Korea

17. Competitive Landscape

• 17.1. Market Concentration Analysis, 2025
  • 17.1.1. Concentration Ratio (CR)
  • 17.1.2. Herfindahl Hirschman Index (HHI)
• 17.2. Recent Developments & Impact Analysis, 2025
• 17.3. Product Portfolio Analysis, 2025
• 17.4. Benchmarking Analysis, 2025

18. Company Profiles

• 18.1. Accuryn Medical
• 18.2. AngioDynamics Inc
• 18.3. Applied Medical Technology Inc
• 18.4. Argon Medical Devices Inc
• 18.5. B. Braun Melsungen AG
• 18.6. Becton Dickinson and Company
• 18.7. Biometrix Ltd
• 18.8. Boston Scientific Corporation
• 18.9. C2DX Inc
• 18.10. ConvaTec Group PLC
• 18.11. Cook Medical LLC
• 18.12. Critical Care Diagnostics Inc
• 18.13. Delta Med SpA
• 18.14. Gaeltec Devices Ltd
• 18.15. Getinge AB
• 18.16. Hill-Rom Holdings Inc
• 18.17. ICU Medical Inc
• 18.18. Laborie Medical Technologies
• 18.19. Medline Industries LP
• 18.20. Nutrimetics SA
• 18.21. Potrero Medical Inc
• 18.22. SAM Medical Products
• 18.23. Spiegelberg GmbH & Co KG
• 18.24. SSEM Mthembu Medical Pty Ltd
• 18.25. Stryker Corporation
• 18.26. Teleflex Incorporated
• 18.27. Verathon Inc
• 18.28. Vygon SAS